Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > The $ 6.4 Billion Question- revisited.

<< Previous

Bullboard Posts

Next >>

Comment by Domino55on Dec 07, 2021 2:02pm

128 Views

Post# 34207262

RE:The $ 6.4 Billion Question- revisited.

Insiders benefit from the avoidance of certain topics.

insiders benefit from low share prices (off a solid 15%since Kellum stated publicly that the trial was going very well).

EDT is almost exclusively about lots of options and all insider financings.

Covid is yesterday's news as we were told.

Setting up nicely for the All Red shareholder presentation tomorrow.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide